Investigating the effect of dehydromiltirone on septic AKI using a network pharmacology method, molecular docking, and experimental validation

被引:0
|
作者
Chen, Sijia [1 ]
Wang, Yanzhe [1 ]
Liu, Yuyuan [2 ]
Bai, Linnan [3 ]
Li, Fengqin [1 ]
Wu, Yue [1 ]
Xie, Xinmiao [1 ]
Zhang, Nan [1 ]
Zeng, Chuchu [1 ]
Zhang, Ling [4 ]
Wang, Xiaoxia [1 ]
机构
[1] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Nephrol, Sch Med, Shanghai, Peoples R China
[2] Nanjing Med Univ, Suzhou Hosp, Suzhou Municipal Hosp, Dept Nephrol, Suzhou, Jiangsu, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Nephrol, Sch Med, Hangzhou, Peoples R China
[4] Univ Elect Sci & Technol China, Chengdu Womens & Childrens Cent Hosp, Sch Med, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
septic AKI; network pharmacology; dehydromiltirone; COX2; apoptosis; mitochondrial dysfunction; inflammatory; CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; SEVERE SEPSIS; MITOCHONDRIA; DYSFUNCTION;
D O I
10.3389/fphar.2023.1145675
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acute kidney injury (AKI) is a severe and frequent complication of sepsis that occurs in intensive care units with inflammation and rapid decline in renal function as the main pathological features. Systemic inflammation, microvascular dysfunction, and tubule injury are the main causes of sepsis-induced AKI (SI-AKI). The high prevalence and death rate from SI-AKI is a great challenge for clinical treatment worldwide. However, in addition to hemodialysis, there is no effective drug to improve renal tissue damage and alleviate the decline in kidney function. We conducted a network pharmacological analysis of Salvia miltiorrhiza (SM), a traditional Chinese medicine, which is widely used for the treatment of kidney disease. Then, we combined molecular docking and a dynamics simulation to screen for the active monomer dehydromiltirone (DHT) that has therapeutic effects on SI-AKI and investigated its potential mechanism of action through experimental validation. The components and targets of SM were obtained by searching the database, and 32 overlapping genes were screened by intersection analysis with AKI targets. GO and KEGG data showed that the functions of a common gene were closely related to oxidative stress, mitochondrial function, and apoptosis. The molecular docking results combined with molecular dynamics simulations provide evidence for a binding model between DHT and cyclooxygenase-2 (COX2), both of which are mainly driven by van der Waals interactions and a hydrophobic effect. In vivo, we found that mice pretreated with an intraperitoneal injection of DHT (20 mg/kg/d) for 3 days ameliorated CLP surgery-induced renal function loss and renal tissue damage and inhibited inflammatory mediators IL-6, IL-1 beta, TNF-a, and MCP-1 production. In vitro, the DHT pretreatment decreased LPS-induced expression of COX2, inhibited cell death and oxidative stress, alleviated mitochondrial dysfunction, and restrained apoptosis in HK-2 cells. Our research indicates that the renal preventive effect of DHT is related to maintaining mitochondrial dynamic balance, restoring mitochondrial oxidative phosphorylation, and inhibiting cell apoptosis. The findings in this study provide a theoretical basis and a novel method for the clinical therapy of SI-AKI.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Chlorogenic acid attenuates idiopathic pulmonary fibrosis: An integrated analysis of network pharmacology, molecular docking, and experimental validation
    Velazquez-Enriquez, Juan Manuel
    Santos-Alvarez, Jovito Cesar
    Ramirez-Hernandez, Alma Aurora
    Reyes-Jimenez, Edilburga
    Mayoral, Laura Perez-Campos
    Romero-Tlalolini, Maria de los Angeles
    Jimenez-Martinez, Cristian
    Arellanes-Robledo, Jaime
    Villa-Trevino, Saul
    Vasquez-Garzon, Veronica Rocio
    Baltierrez-Hoyos, Rafael
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 734
  • [42] Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation
    Jiang, Yunzhong
    Zhang, Mengzhao
    Wang, Lu
    Zhang, Lu
    Ma, Minghai
    Jing, Minxuan
    Li, Jianpeng
    Song, Rundong
    Zhang, Yuanquan
    Yang, Zezhong
    Zhang, Yaodong
    Pu, Yuanchun
    Qu, Xiaowei
    Fan, Jinhai
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [43] Exploring the Therapeutic Potential and Underlying Mechanism of Bergapten in Renal Fibrosis: Network Pharmacology, Molecular Docking, and Experimental Validation
    Gairola, Shobhit
    Saini, Montu
    Bhatta, Archana
    Kaundal, Ravinder K.
    PHYTOTHERAPY RESEARCH, 2025,
  • [44] Uncovering the Mechanisms of Cinnamic Acid Treating Diabetic Nephropathy based on Network Pharmacology, Molecular Docking, and Experimental Validation
    Dai, Limiao
    He, Yang
    Zheng, Siqiang
    Tang, Jiyu
    Fu, Lanjun
    Zhao, Li
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2024,
  • [45] Combining Network Pharmacology, Molecular Docking and Experimental Validation to Explore the Effects and Mechanisms of Indirubin on Acute Lymphoblastic Leukemia
    Jin, Lu
    Guan, Yunshuang
    Li, Xue
    Wang, Mingyue
    Shen, Ying
    Wang, Nianxue
    He, Zhixu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 1083 - 1103
  • [46] Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation
    Chen, Shengnan
    Li, Bo
    Chen, Lei
    Jiang, Hongli
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [47] Mechanism exploration of 6-Gingerol in the treatment of atherosclerosis based on network pharmacology, molecular docking and experimental validation
    Hu, Youdong
    Liu, Tingting
    Zheng, Guangzhen
    Zhou, Li
    Ma, Ke
    Xiong, Xiaolian
    Zheng, Cheng
    Li, Jin
    Zhu, Yong
    Bian, Wenhui
    Zheng, Xiangde
    Xiong, Qingping
    Lin, Jiafeng
    PHYTOMEDICINE, 2023, 115
  • [48] Exploring the mechanism of Buxue Yimu Pill on hemorrhagic anemia through molecular docking, network pharmacology and experimental validation
    XIONG Yan
    CAO Xu-Yuan
    LIU Bo-Yu
    DAI Yong-Qi
    ZHOU Heng-Jun
    HE Juan-Juan
    GONG Yun
    WU Xue-Wen
    TANG Huai-Bo
    Chinese Journal of Natural Medicines, 2021, 19 (12) : 900 - 911
  • [49] Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of Qifu Longkui Decoction in the Treatment of Colorectal Cancer
    Xiong, Yaling
    Liu, Yihao
    Chen, Xia
    Tang, Shuiwen
    Jian, Zhiyuan
    NATURAL PRODUCT COMMUNICATIONS, 2024, 19 (12)
  • [50] Network pharmacology combined with molecular docking and experimental validation of the mechanism of action of columbianetin acetate in the treatment of ovarian cancer
    Hu, Mengling
    Wang, Luyao
    Zhang, Feiyue
    Xie, Yiluo
    Zhang, Tingting
    Liu, Hongli
    Li, Zhenghong
    Zhang, Jing
    FRONTIERS IN ONCOLOGY, 2025, 15